Personal information

No personal information available

Activities

Employment (1)

Pontificia Universidad Católica de Chile: Santiago, CL

2015-07-01 to present | Assitant Professor (Departamento de Gastroenterología)
Employment
Source: Self-asserted source
Francisco Barrera

Education and qualifications (3)

Pontificia Universidad Católica de Chile: Santiago, CL

Physician (Escuela de Medicina)
Education
Source: Self-asserted source
Francisco Barrera

Pontificia Universidad Catolica de Chile Escuela de Medicina: Santiago, Metropolitana, CL

2011-01-01 to present | Gastroenterologist (Departamento de Gastroenterología)
Education
Source: Self-asserted source
Francisco Barrera

Pontificia Universidad Catolica de Chile Escuela de Medicina: Santiago, CL

2008-01-01 to present | Internal medicine (Departamento de Medicina Interna)
Education
Source: Self-asserted source
Francisco Barrera

Professional activities (4)

Sociedad Chilena de Gastroenterología: Santiago, Metropolitana, CL

Premio Ivan Marinovic
Distinction
Source: Self-asserted source
Francisco Barrera

Sociedad Chilena de Gastroenterología: Santiago, Metropolitana, CL

Premio Investigador Joven Jaime Chesta 2014
Distinction
Source: Self-asserted source
Francisco Barrera

European Association for the Study of the Liver: Geneve, GE, CH

2015-01-01 to present | regular
Membership
Source: Self-asserted source
Francisco Barrera

American Association for the Study of Liver Diseases: Alexandria, VA, US

2014-01-01 to present | regular
Membership
Source: Self-asserted source
Francisco Barrera

Funding (1)

ador principal FONDECYT regular 1191183 "Dissecting therapeutic role of Growth Hormone and Insulin-Like Growth Factor 1 in chronic liver disease: balancing betwenn hepatocyte protection and oncogenic potential"

Grant
CONICYT (Santiago, CL)
GRANT_NUMBER:

1191183

Source: Self-asserted source
Francisco Barrera

Works (30)

Concurrent nonalcoholic liver disease and type 2 diabetes: diagnostic and therapeutic considerations.

Expert review of gastroenterology & hepatology
2019-07 | Journal article
Contributors: Arrese M; Barrera F; Triantafilo N; Arab JP
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Accuracy of the BAR score in the prediction of survival after liver transplantation.

Annals of hepatology
2019-03 | Journal article
Contributors: Martínez JA; Pacheco S; Bachler JP; Jarufe N; Briceño E; Guerra JF; Benítez C; Wolff R; Barrera F; Arrese M
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

[Liver transplantation in a patient with human immunodeficiency virus (HIV). Case report].

Revista medica de Chile
2018-12 | Journal article
Contributors: Guerra JF; Troncoso A; Ceballos ME; Arrese M; Barrera F; Norero B; Soza A; Rivas V; Wolff R; Arias A et al.
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

The evolving role of liver biopsy in non-alcoholic fatty liver disease.

Annals of hepatology
2018-11 | Journal article
Contributors: Arab JP; Barrera F; Arrese M
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Somatotropic Axis Dysfunction in Non-Alcoholic Fatty Liver Disease: Beneficial Hepatic and Systemic Effects of Hormone Supplementation.

International journal of molecular sciences
2018-05 | Journal article
Contributors: Cabrera D; Cabello-Verrugio C; Solís N; San Martín D; Cofré C; Pizarro M; Arab JP; Abrigo J; Campos F; Irigoyen B et al.
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review.

Journal of viral hepatitis
2018-04 | Journal article
Contributors: Goossens N; de Vito C; Mangia A; Clément S; Cenderello G; Barrera F; D'Ambrosio R; Coppola N; Zampino R; Stanzione M et al.
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Nonalcoholic fatty liver disease, cholesterol gallstones, and cholecystectomy: new insights on a complex relationship.

Current opinion in gastroenterology
2018-03 | Journal article
Contributors: Arrese M; Cortés V; Barrera F; Nervi F
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Is flumazenil an alternative for the treatment of hepatic encephalopathy?

Medwave
2017-12 | Journal article
Contributors: Reyes D; Barrera F
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Bile Acids and Portal Hypertension.

Annals of hepatology
2017-11 | Journal article
Contributors: Pablo Arab J; Barrera F; Arrese M
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis.

Scientific reports
2017-06 | Journal article
Contributors: Cabrera D; Wree A; Povero D; Solís N; Hernandez A; Pizarro M; Moshage H; Torres J; Feldstein AE; Cabello-Verrugio C et al.
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population.

Gastroenterologia y hepatologia
2017-03 | Journal article
Contributors: Arab JP; Hernández-Rocha C; Morales C; Vargas JI; Solís N; Pizarro M; Robles C; Sandoval D; Ponthus S; Benítez C et al.
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Sublingual tacrolimus administration provides similar drug exposure to per-oral route employing lower doses in liver transplantation: a pilot study.

Alimentary pharmacology & therapeutics
2017-03 | Journal article
Contributors: Solari S; Cancino A; Wolff R; Norero B; Vargas JI; Barrera F; Guerra JF; Martínez J; Jarufe N; Soza A et al.
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Conversion to Mycophenolate Mofetil Monotherapy in Liver Recipients: Calcineurin Inhibitor Levels are Key.

Annals of hepatology
2017-01 | Journal article
Contributors: Norero B; Serrano CA; Sanchez-Fueyo A; Duarte I; Torres J; Ocquetau M; Barrera F; Arrese M; Soza A; Benítez C
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

High prevalence of undiagnosed liver cirrhosis and advanced fibrosis in type 2 diabetic patients.

Annals of hepatology
2016-09 | Journal article
Contributors: Arab JP; Barrera F; Gallego C; Valderas JP; Uribe S; Tejos C; Serrano C; Huete Á; Liberona J; Labbé P et al.
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1.

Digestive diseases and sciences
2016-08 | Journal article
Contributors: Cabrera D; Ruiz A; Cabello-Verrugio C; Brandan E; Estrada L; Pizarro M; Solis N; Torres J; Barrera F; Arrese M
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease.

Liver international : official journal of the International Association for the Study of the Liver
2016-05 | Journal article
Contributors: Kazankov K; Barrera F; Møller HJ; Rosso C; Bugianesi E; David E; Younes R; Esmaili S; Eslam M; McLeod D et al.
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Effect of cholecystectomy on bile acid synthesis and circulating levels of fibroblast growth factor 19.

Annals of hepatology
2015-09 | Journal article
Contributors: Barrera F; Azócar L; Molina H; Schalper KA; Ocares M; Liberona J; Villarroel L; Pimentel F; Pérez-Ayuso RM; Nervi F et al.
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients.

PloS one
2015-09 | Journal article
Contributors: Nielsen MJ; Kazankov K; Leeming DJ; Karsdal MA; Krag A; Barrera F; McLeod D; George J; Grønbæk H
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Prediction of Esophageal Variceal Bleeding in Liver Cirrhosis: Is There a Role for Hemostatic Factors?

Seminars in thrombosis and hemostasis
2015-06 | Journal article
Contributors: Barrera F; Zúñiga P; Arrese M
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Obeticholic acid: expanding the therapeutic landscape of NASH.

Annals of hepatology
2015-05 | Journal article
Contributors: Arrese M; Cabrera D; Barrera F
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis.

Liver international : official journal of the International Association for the Study of the Liver
2015-02 | Journal article
Contributors: Pizarro M; Solís N; Quintero P; Barrera F; Cabrera D; Rojas-de Santiago P; Arab JP; Padilla O; Roa JC; Moshage H et al.
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Mycobacterium abscessus pulmonary infection during hepatitis C treatment with telaprevir, peginterferon and ribavirin.

Annals of hepatology
2015-01 | Journal article
Contributors: Soza A; Labbé P; Arrese M; Riquelme A; Barrera F; Benítez C; Huete A; Balcells ME; Labarca J
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.

PLoS medicine
2014-07 | Journal article
Contributors: Musso G; Gambino R; Tabibian JH; Ekstedt M; Kechagias S; Hamaguchi M; Hultcrantz R; Hagström H; Yoon SK; Charatcharoenwitthaya P et al.
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.

Hepatology (Baltimore, Md.)
2014-05 | Journal article
Contributors: Kazankov K; Barrera F; Møller HJ; Bibby BM; Vilstrup H; George J; Grønbaek H
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Prothrombotic factors and nonalcoholic fatty liver disease: an additional link to cardiovascular risk?

Hepatology (Baltimore, Md.)
2013-11 | Journal article
Contributors: Barrera F; George J
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

The role of diet and nutritional intervention for the management of patients with NAFLD.

Clinics in liver disease
2013-10 | Journal article
Contributors: Barrera F; George J
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease.

Gastroenterology
2013-07 | Journal article
Contributors: Angulo P; Bugianesi E; Bjornsson ES; Charatcharoenwitthaya P; Mills PR; Barrera F; Haflidadottir S; Day CP; George J
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

[Quantification of visceral adipose tissue using magnetic resonance imaging compared with anthropometry, in type 2 diabetic patients].

Revista medica de Chile
2012-12 | Journal article
Contributors: Serrano García C; Barrera F; Labbé P; Liberona J; Arrese M; Irarrázabal P; Tejos C; Uribe S
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Oxidative stress is closely associated with insulin resistance in genotypes 1 and 3 chronic hepatitis C.

Hepatology international
2012-09 | Journal article
Contributors: Hashemi SM; van der Poorten D; Barrera F; Bandara P; Lux O; Kench J; George J
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central

Platelet count/spleen diameter ratio for non-invasive prediction of high risk esophageal varices in cirrhotic patients.

Annals of hepatology
2009-10 | Journal article
Contributors: Barrera F; Riquelme A; Soza A; Contreras A; Barrios G; Padilla O; Viviani P; Pérez-Ayuso RM
Source: Self-asserted source
Francisco Barrera via Europe PubMed Central